TipRanks on MSN

Neurocrine price target raised to $179 from $171 at JPMorgan

JPMorgan analyst Anupam Rama raised the firm’s price target on Neurocrine (NBIX) to $179 from $171 and keeps an Overweight rating on the shares.
Business.com on MSN

Gusto vs. ADP: Which Payroll Software Is Right for Your Business?

This comparison guide breaks down the similarities and differences between ADP and Gusto payroll solutions for small ...